The Cooper Companies, Inc. (COO)

The Cooper Companies, Inc. is a Healthcare company in the S&P 500, with a market capitalization of about $10.8 billion as of October 1, 2026.

Ticker: COO · Nasdaq
Sector: Healthcare
Industry (SIC): Ophthalmic Goods
Market cap: $10.8 billion
Employees: 15,000
Headquarters: San Ramon, CA
Fiscal year end: October 31

About The Cooper Companies, Inc.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Financial statements

Nvevo shows The Cooper Companies, Inc.'s income statement, balance sheet, cash flow statement and key ratios as reported in its 10-K and 10-Q filings with the SEC, annually and quarterly, alongside price history, recent news and fair value models.

Other Healthcare companies

Research another company · Market map · Stock screener · Compare companies